Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Momentum now, May 25 (ASCO reveal) and After

<< Previous

Bullboard Posts

Next >>

Post by SundayMovieson May 08, 2023 4:19pm

363 Views

Post# 35437164

Momentum now, May 25 (ASCO reveal) and After

My guess is that we break 2 USD$ before May 25th 2023 (ASCO Reveal Day).

After ASCO, we are 4-5$ and by June after KOL, we are in the 6 USD$ range.

So abour 600 millions company - with 2 PIII ready applications.

Traders, momentum players and long term investors. Let's go to the Moon and beyond. Jupiter maybe?

After that we wait for partnership, which will again reset share price higher...

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December